Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-15 of 15 for

Edit search filters
  1. Lp-PLA2 and Coronary Atherosclerosis in Humans

    Rochester, MN

  2. A Study to Evaluate the Process of Aging in Human Atherosclerosis

    Rochester, MN

  3. AI System for Cardiovascular Risk Factors

    Scottsdale/Phoenix, AZ

  4. Systolic Pressure Intervention Trial Factors Affecting Atherosclerosis Study

    Jacksonville, FL

  5. Florida Cerebrovascular Disease Biorepository and Genomics Center

    Jacksonville, FL


Mayo Clinic Footer